FDA approves drug to treat Parkinson ’ s disease

The U.S. Food and Drug Administration today approved Xadago (safinamide) tablets as an add-on treatment for patients with Parkinson ’ s disease who are currently taking levodopa/carbidopa and experiencing “ off ” episodes. An “ off ” episode is a time when a patient ’ s medications are not working well, causing an increase in Parkinson ’ s symptoms, such as tremor and difficulty walking.
Source: Food and Drug Administration - Category: American Health Source Type: news